This study is in progress, not accepting new patients
Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
Summary
- Eligibility
- for people ages 18-99 (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Amgen
- Links
- AmgenTrials clinical trials website
- ID
- NCT04260191
- Phase
- Phase 1 Research Study
- Study Type
- Interventional
- Participants
- At least 16 people participating
- Last Updated